PubRank

M Vesanen

Author PubWeight™ 38.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997 13.68
2 Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N Engl J Med 1999 7.07
3 Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy. J Virol 1999 3.15
4 Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J Exp Med 1999 2.33
5 The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses. J Infect Dis 1999 2.27
6 Human spumaretrovirus in the etiology of sudden hearing loss. Acta Otolaryngol 1993 1.49
7 Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-associated lymphoid tissue. J Acquir Immune Defic Syndr 2001 1.22
8 Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia. Virology 2000 1.14
9 Molecular tracking of an Human Immunodeficiency Virus nef specific cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor DNA but not mRNA following early combination antiretroviral therapy. Immunol Lett 1999 1.12
10 An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. Mol Med 2000 0.94
11 Identification of human type D retrovirus as a contaminant in a neuroblastoma cell line. Arch Virol 1993 0.83
12 Ovarian cysts in dairy cattle--some aspects of diagnosis, treatment with GnRH and HCG and subsequent milk progesterone values. Nord Vet Med 1984 0.82
13 Complement and c4 null alleles in severe chronic adult periodontitis. Scand J Immunol 2007 0.81
14 Open-label phase II trial of amprenavir, abacavir, and fixed-dose zidovudine/lamivudine in newly and chronically HIV-1--infected patients. J Acquir Immune Defic Syndr 2001 0.79
15 Human spumaretrovirus in the etiology of sudden hearing loss. Acta Otolaryngol 1994 0.79